MLN8054 Terminated Phase 1 Trials for Neoplasms, Pancreatic / Colon Neoplasms / Neoplasm, Bladder / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00249301A Study of MLN8054 in Patients With Advanced Solid Tumors